Novartis Pharma AG: Novartis presents new data in breast and prostate cancer at ESMO

Overall survival results from pooled exploratory analysis of MONALEESA trials in patients with aggressive HR+/HER2- advanced breast cancer treated with Kisqali Data from VISION study reporting associations

Related Keywords

United States ,America ,Isabella Zinck ,Jeff Legos ,Nicole Zinsli Somm ,Samir Shah ,Julie Masow ,Parag Mahanti ,Sloan Simpson ,Alina Levchuk ,Novartis Institutes For Biomedical Research ,Twitter ,Astex Pharmaceuticals ,Novartis Oncology Communications ,Novartis Us External Communications ,Novartis External Communications ,Novartis ,Exchange Commission ,Global Head Of Oncology Hematology Development ,European Society For Medical Oncology ,European Society ,Medical Oncology ,Executive Vice President ,Global Head ,Hematology Development ,Novartis Institutes ,Biomedical Research ,Dharma ,Presents ,Data ,Breast ,Prostate ,Dancer ,Osmo ,